Multiple Sclerosis (MS) Drugs
Additional Reading
Arthritis during interferon beta-1b treatment in multiple sclerosis
"Arthritis during interferon beta-1b treatment in multiple sclerosis"
Altintas A, Alici Y, Melikoglu M, Siva A.
Department of Neurology, Cerrahpasa School of Medicine, 34300 Istanbul, Turkey. aaltintas.md@superonline.com
Interferon beta (IFN-beta) is the most widely prescribed disease-modifying drug for multiple sclerosis (MS). Therapy with IFN-beta may be associated with a number of adverse reactions.
The development or exacerbation of other autoimmune diseases is a rare but reported side effect of IFN-beta therapy.
In this case report, we present clinical and laboratory findings of two MS patients who developed arthritis during IFN-beta1b treatment, probably of autoimmune origin.
Mult Scler. 2002 Dec;8(6):534-6.
PMID: 12474998 [PubMed link]